Enzyme Family ABPP Service for Selectivity and Activity Profiling

Family-focused activity-state, inhibitor selectivity, and off-target profiling by activity-based probe labeling and LC-MS/MS.

Enzyme Family ABPP is a focused activity-based protein profiling workflow that uses family-selective probes, enrichment, LC-MS/MS, and bioinformatics analysis to measure activity states and selectivity patterns across related enzymes. It helps connect inhibitor response, enzyme activity, off-target effects, and follow-up validation priorities within a defined enzyme family.

A single enzyme assay can confirm one target, but it may not show what happens across the rest of the enzyme family. If your inhibitor, covalent ligand, treatment, or activity-based probe affects related enzymes, you need a family-wide activity readout.

At Creative Proteomics, our Enzyme Family ABPP Service for Selectivity and Activity Profiling helps research teams profile activity states, inhibitor selectivity, and same-family off-target effects across selected enzyme families. We support probe feasibility review, family-selective labeling, competition design, LC-MS/MS analysis, enzyme family annotation, and decision-ready reporting.

Key Advantages:

  • Family-wide enzyme activity profiling.
  • Inhibitor selectivity and off-target mapping.
  • Family-selective probe strategy.
  • LC-MS/MS protein and peptide evidence.
  • Enzyme heatmaps and target prioritization.
Enzyme family ABPP workflow for selectivity profiling and LC-MS/MS target prioritization.
Activity and Selectivity Capabilities Workflow Project Types Sample Deliverables Demo Comparison Case Study FAQ Feasibility Review Disclaimer

Measure Activity and Selectivity Across a Selected Enzyme Family

Enzyme-family-specific ABPP is designed for projects where one enzyme family is the main question. Instead of measuring total protein abundance, the workflow uses activity-based probes to label active enzymes or probe-accessible active sites within a selected family.

This is useful when you need to understand whether a compound affects only the intended enzyme, whether it also interacts with related family members, or whether a disease model changes activity across a family of enzymes.

A standard protein abundance profile can show expression changes, but it may miss enzyme activity changes. A single biochemical assay can validate one target, but it may not reveal same-family off-targets. Enzyme Family ABPP fills the gap between broad proteomics and single-target validation.

What Enzyme Family ABPP Helps You See

Depending on probe chemistry, sample format, and LC-MS/MS depth, this service can help you evaluate:

  • Active enzyme family members.
  • Inhibitor selectivity across related enzymes.
  • Same-family off-target candidates.
  • Treatment versus control activity shifts.
  • Disease model enzyme activity patterns.
  • Protein-level family activity evidence.
  • Peptide or active-site evidence where supported.
  • Enzyme targets for follow-up validation.

Enzyme Families That May Be Considered

Examples include serine hydrolases, cysteine proteases, deubiquitylating enzymes, kinases, metalloproteases, proteasome-related enzymes, and project-specific probe-covered families.

Not every enzyme family is suitable for ABPP. The feasibility depends on probe availability, active-site chemistry, sample type, enzyme abundance, labeling conditions, and the level of evidence required.

For foundational activity-based profiling, see our Activity-Based Protein Profiling (ABPP-MS) service.

Our Enzyme-Family-Specific ABPP Service Capabilities

A successful enzyme family ABPP project starts with the right question: Which enzyme family do you want to profile, and what decision will the data support?

Our team helps design and execute a family-focused ABPP workflow that connects probe chemistry, sample preparation, LC-MS/MS evidence, and enzyme family interpretation.

Enzyme Family and Probe Feasibility Review

Before project launch, we review the selected enzyme family, available activity-based probe, compound or inhibitor, sample type, and intended readout.

We help assess:

  • Whether the enzyme family is suitable for ABPP.
  • Whether a family-selective probe is available.
  • Whether the probe is expected to label active family members.
  • Whether the project needs competition design.
  • Whether protein-level or site-level evidence is expected.
  • Whether live-cell, lysate, tissue, or purified enzyme format is best.
  • Whether Global ABPP or Competitive ABPP should be included.

For broader activity profiling beyond one family, see our Global ABPP and LC-MS/MS Chemoproteomics service.

Family-Selective Probe Labeling and Competition Design

Family-selective activity-based probes usually take advantage of shared active-site chemistry within an enzyme family. When an inhibitor or covalent ligand is included, competition design can help show which family members are affected by the compound.

Depending on project goals, the design may include:

  • Probe-only labeling.
  • Vehicle control.
  • Inhibitor-treated samples.
  • Dose or competition series.
  • Treatment versus control groups.
  • Disease model comparison.
  • Biological replicates.

For projects centered on compound occupancy and competition, see our Competitive ABPP service.

Lysate, Live-Cell, Tissue, and Focused Validation Formats

Cell lysate workflows are useful when you need controlled protein concentration, buffer conditions, and compound exposure. Live-cell workflows are useful when cellular permeability and intact-cell engagement matter. Tissue lysates can support disease model or pathway model enzyme activity profiling when sufficient material and matched controls are available.

For cellular-context studies, see our Live-cell ABPP service.

Enrichment, Digestion, and LC-MS/MS Analysis

After labeling, probe-labeled proteins or peptides are enriched, washed, digested, and analyzed by LC-MS/MS. The final result may include protein-level enzyme family profiles, peptide-level evidence, or active-site evidence where the workflow supports it.

We focus on enrichment specificity, digestion quality, LC stability, MS signal quality, and replicate consistency.

Enzyme Family Annotation and Target Prioritization

We help organize LC-MS/MS results into a family-focused interpretation package. This may include enzyme family heatmaps, inhibitor selectivity tables, off-target candidate lists, peptide/site evidence summaries, and QC notes.

The goal is not just to produce a long protein table. The goal is to help your team decide which enzyme family members deserve follow-up validation.

From Family Probe Design to LC-MS/MS Evidence: Workflow and QC Checkpoints

Our workflow follows the project from enzyme family review to final data delivery.

1

Enzyme Family and Probe Strategy Review

We begin by reviewing the selected enzyme family, probe class, inhibitor or compound, sample format, comparison groups, and expected evidence level.

QC checkpoint: enzyme family suitability, probe availability, probe selectivity, sample format, controls, and expected readout.

2

Sample Treatment, Inhibitor Competition, or Probe Labeling

Samples are prepared under matched conditions. Depending on the design, the workflow may include direct probe labeling, inhibitor competition before probe labeling, treatment-control comparison, or disease-control comparison.

QC checkpoint: sample consistency, inhibitor exposure, probe labeling conditions, treatment matching, biological replicates, and control behavior.

3

Enrichment, Cleanup, and Protein Digestion

Probe-labeled enzymes or peptides are enriched and washed to reduce background. Proteins are digested into peptides for LC-MS/MS analysis.

QC checkpoint: enrichment specificity, background binding, protein recovery, digestion quality, and control performance.

4

LC-MS/MS Acquisition and Identification

Prepared peptides are analyzed by LC-MS/MS. The acquisition strategy depends on sample complexity, target family size, and whether protein-level or site-level evidence is expected.

QC checkpoint: LC stability, MS signal quality, peptide identification, family member detection, and replicate alignment.

5

Family Heatmap, Selectivity Table, and Report Delivery

The final data are organized into enzyme family tables, family heatmaps, inhibitor selectivity comparisons, peptide/site evidence summaries, QC summaries, and target prioritization outputs.

QC checkpoint: family annotation, missing value review, competition response, site evidence where available, and interpretation boundary.

Vertical enzyme family ABPP workflow with probe feasibility, labeling, enrichment, LC-MS/MS, and family annotation.

Project Types Supported by Enzyme Family ABPP

Family-Wide Enzyme Activity Profiling

This workflow can show how activity-linked signals vary across members of a selected enzyme family. It is useful when the family, not one isolated target, is the central biological question.

Inhibitor Selectivity and Same-Family Off-Target Mapping

A compound may inhibit the intended enzyme but also affect related family members. Enzyme Family ABPP helps profile these same-family off-target candidates. For covalent compounds, see our Covalent Inhibitor Profiling service.

Treatment-Control Activity-State Comparison

Drug treatment, stress, mutation, disease state, or pathway perturbation may shift enzyme activity without changing total protein abundance. Enzyme Family ABPP can compare treated and control samples to reveal these activity-state patterns.

Disease Model or Tissue Enzyme Activity Landscape

Tissue lysate studies may help reveal enzyme family activity changes across disease models, tissues, or treatment groups. These studies require careful sample matching and matrix-background review.

Live-Cell or Lysate Enzyme Family Profiling

Live-cell and lysate workflows answer different questions. Live-cell studies reflect cellular access and context, while lysate studies provide more controlled biochemical exposure.

Focused Follow-Up After Global ABPP

Global ABPP may identify a broad activity pattern. Enzyme-family-specific ABPP can then focus on one family for deeper activity mapping, selectivity review, or validation prioritization.

Sample, Probe, Compound, and Control Requirements

Final requirements depend on enzyme family, probe chemistry, sample type, protein yield, and analysis depth. The table below provides practical planning values. Exact requirements are confirmed during feasibility review.

Sample / MaterialRecommended AmountRequired InformationControls to PrepareStorage and ShippingNotes
Cell lysate or cell pellet5 × 106 to 1 × 107 cells for proteomics-scale planningCell line, enzyme family, lysis method, treatment conditionVehicle, no-probe, probe-only, competition, biological replicatesFlash-freeze, store at -80°C, ship on dry iceUseful for family-wide activity profiling
Live-cell sampleProject-dependentCell line, probe permeability expectation, treatment designVehicle, probe-only, treatment/control, competition if neededProcess as agreed after feasibility reviewUseful when cellular context matters
Tissue lysate30–50 mg for trace proteomics; 100–200 mg for broader planningSpecies, tissue type, enzyme family, treatment groupMatched controls and biological replicatesFlash-freeze, store at -80°C, ship on dry iceUseful for disease model enzyme activity
Purified enzyme / focused panelAbout 150–300 μg as a practical planning rangeEnzyme identity, buffer, concentration, expected activityEnzyme-only, probe-only, inhibitor controlFrozen or cold-chain as agreedUseful for follow-up validation
Family-selective probeProject-dependentProbe structure, warhead, tag, covered enzyme familyNo-probe and probe-only controlsShip according to probe stabilityCore feasibility input
Inhibitor / covalent ligandProject-dependentStructure, solvent, stock concentration, expected targetVehicle and dose/competition groupsShip according to compound stabilityRequired for selectivity profiling

Please label biological replicates clearly, avoid repeated freeze-thaw cycles, and provide detailed notes on treatment timing, compound concentration, solvent, and expected enzyme family.

What You Receive: Enzyme Family ABPP Data Package and Bioinformatics Analysis

Enzyme Family ABPP generates data that must be interpreted within the selected family. We organize the results so your team can move from LC-MS/MS output to activity and selectivity decisions.

Minimum Deliverables

  • Raw LC-MS/MS data files.
  • Enzyme family activity table.
  • Enzyme family heatmap.
  • Inhibitor competition or selectivity comparison table.
  • Protein identification table.
  • Probe-labeled peptide or site table where supported.
  • Replicate-level quantitative summary.
  • QC summary.
  • Method summary.
  • Prioritized enzyme target/off-target candidate list.
  • Visualization-ready figures.

Optional Analysis Add-ons

  • Protein family annotation refinement.
  • Pathway enrichment analysis.
  • Site-level prioritization.
  • Compound-series selectivity comparison.
  • Live-cell versus lysate comparison.
  • Integration with Global ABPP, Competitive ABPP, or Live-cell ABPP.
  • Follow-up validation recommendation table.

For residue-specific interpretation, see our Reactive Residue Profiling service.

How We Help Interpret the Data

We help answer practical questions:

  • Which enzyme family members were detected?
  • Which family members changed after treatment or competition?
  • Which signals may be background or associated proteins?
  • Which proteins have peptide or site-level evidence?
  • Which family members may be same-family off-targets?
  • Which results should move into biochemical validation?

Representative Demo Results for Enzyme Family ABPP

The following demo outputs show how enzyme family ABPP data can be presented. These are representative output formats, not client-specific claims.

Demo enzyme family ABPP results showing activity heatmap, inhibitor selectivity, and target evidence dashboard.

Integrated enzyme family ABPP demo results panel

Family heatmap, inhibitor selectivity plot, and target/site evidence dashboard.

Demo 1: Enzyme Family Activity Heatmap

A family heatmap can show probe-labeling intensity across control, treatment, and competition groups.

How to read it: A useful pattern may show selective reduction or enrichment of specific family members while other related enzymes remain unchanged.

Demo 2: Inhibitor Selectivity and Off-Target Plot

A selectivity plot can summarize which family members respond to an inhibitor or covalent ligand.

How to read it: The intended target should be interpreted together with same-family off-targets, dose response, peptide evidence, and replicate consistency.

Demo 3: Target and Site Evidence Dashboard

A dashboard can combine enzyme name, family annotation, peptide evidence, site evidence where available, enrichment ratio, competition response, and confidence tier.

How to read it: This view helps turn a family-wide profile into a shortlist for validation and lead optimization.

Enzyme Family ABPP vs Other Enzyme and Proteomics Workflows

Different workflows answer different questions. We help choose the method based on whether your goal is family activity mapping, broad discovery, inhibitor competition, cellular engagement, abundance response, or single-target validation.

MethodBest Use CaseEvidence LevelStrengthLimitationWhen to Choose
Enzyme Family ABPPFamily-specific activity/selectivity profilingFamily-level protein and peptide/site evidenceFocused functional readout for a selected enzyme familyRequires suitable family-selective probeChoose when one enzyme family is the main question
Global ABPPBroad activity-state or reactive proteome profilingProteome-wide probe-labeled protein/site evidenceBroad discovery viewLess focused on one familyChoose when the target family is not fixed
Competitive ABPPCompound engagement and selectivityCompetition-dependent signal changeStrong for occupancy and selectivityRequires matched probe and compound designChoose when inhibitor competition is central
Live-cell ABPPCellular target engagementIntact-cell probe-labeling evidenceCaptures permeability and cellular contextRequires cell-compatible probeChoose when cellular engagement matters
Standard Quantitative ProteomicsProtein abundance responseAbundance-level evidenceBroad biological responseDoes not directly measure enzyme activityChoose for expression/pathway response
Biochemical Enzyme AssaySingle-target activity validationTarget-specific activity readoutClear focused validationNot family-wideChoose after ABPP prioritizes targets

How to Choose the Right Workflow

Choose Enzyme Family ABPP when a selected enzyme family is the central question.

Choose Global ABPP when the project needs a broader activity landscape.

Choose Competitive ABPP when compound occupancy and selectivity are the main endpoints.

Choose Live-cell ABPP when cellular permeability and intact-cell engagement matter.

Choose Biochemical Enzyme Assays for focused validation after family-wide prioritization.

Choose Isotope Labeling-Based Quantitative ABPP when site-level quantitative comparison is central to the project. For this route, see our Isotope Labeling-Based Quantitative ABPP service.

For broader enzyme targetability studies, see our Ligandability Mapping service.

Literature-Supported Case Study: Serine Hydrolase Activity Profiling by In-Cell ABPP and LC-MS/MS

This literature-supported case study is based on Shamshurin et al., In situ activity-based protein profiling of serine hydrolases in E. coli. It is not a Creative Proteomics customer case.

Background

The study addressed whether activity-based protein profiling could monitor functional enzyme-family states directly in intact cells. The authors focused on serine hydrolases because members of this family share catalytic features that can be targeted by fluorophosphonate-based activity probes.

The paper also highlights a common limitation of gel-based ABPP: visible gel bands do not always identify the labeled enzyme. The authors therefore used LC-MS/MS after enrichment to identify active serine hydrolases more directly.

Methods

The authors used E. coli K12 cells and a fluorophosphonate-alkyne activity probe to label active serine hydrolases. The probe could react with active serine hydrolases either in intact cells or after cell lysis.

After labeling, the alkyne handle was connected to biotin-azide or TAMRA-azide using CuAAC click chemistry. TAMRA-tagged samples were analyzed by SDS-PAGE fluorescence, while biotin-tagged proteins were enriched with streptavidin and identified by LC-MS/MS.

The study compared in-cell labeling and in-lysate labeling. Biological duplicates were prepared for each labeling condition. Figure 1 shows the experimental design, including in-cell and in-lysate FP-alkyne labeling, click tagging, affinity enrichment, and LC-MS/MS identification. Figure 2 shows fluorescence and Coomassie-stained gel patterns after FP-TAMRA labeling. Table 1 lists the serine hydrolases identified by ABPP enrichment.

Results

The authors first showed that FP-TAMRA labeling generated detectable protein bands in both in-cell and in-lysate samples. In Figure 2, Coomassie-stained total protein patterns were similar across the in-cell, in-lysate, and control samples. This suggested comparable protein loading and no gross disruption of cellular protein composition by probe treatment.

The LC-MS/MS data provided the main family-level result. The authors reported that whole-cell proteomic analysis detected 44 serine hydrolases in E. coli. The FP-alkyne ABPP workflow identified 30 of these serine hydrolases after enrichment, which corresponds to about 68% of the detectable serine hydrolase family in that system.

The study also reported broader proteomic depth. Using 2D-LC-MS, the authors identified 2,496 proteins with two or more unique peptides, representing about 60% of the 4,141 proteins encoded by the E. coli genome. The false-positive rates for ABPP LC-MS/MS searches ranged from 0.7% to 0.93%. The dataset was deposited as PXD000241.

The comparison between in-cell and in-lysate labeling also showed that labeling context matters. The authors observed qualitative differences between the in-cell and lysate labeling patterns. This supports the point that family-specific ABPP results depend on sample state, probe access, and cellular context.

Conclusion

The authors concluded that FP-alkyne ABPP can profile active serine hydrolases in situ and identify a substantial portion, but not all, of the detectable family members. The study shows why enzyme-family-specific ABPP should be interpreted with probe coverage, sample context, enrichment, and LC-MS/MS evidence in mind.

For enzyme-family ABPP projects, this case supports four practical lessons. First, a family-directed probe can produce a focused activity profile across many related enzymes. Second, LC-MS/MS identification provides information that gel-based readouts alone cannot provide. Third, in-cell and lysate labeling can differ, so sample context should be chosen based on the biological question. Fourth, non-detection should not be over-interpreted as lack of enzyme activity because probe coverage is substantial but not complete.

In-cell and in-lysate ABPP workflow for serine hydrolase activity profiling by LC-MS/MS.

Figure 1 from Shamshurin et al., 2014, shows the experimental design for in-cell and in-lysate ABPP labeling of E. coli serine hydrolases using an FP-alkyne probe, click tagging, enrichment, and LC-MS/MS.

FAQ

FAQ: Planning an Enzyme Family ABPP Project

Q: What is Enzyme Family ABPP?

Enzyme Family ABPP is an activity-based protein profiling workflow focused on a selected enzyme family. It uses family-selective probes, enrichment, LC-MS/MS, and bioinformatics to profile activity and selectivity across related enzymes.

Q: How is Enzyme Family ABPP different from Global ABPP?

Global ABPP provides a broader activity-state view across the proteome. Enzyme Family ABPP focuses on one selected enzyme family and provides a more targeted activity and selectivity interpretation.

Q: Which enzyme families can be studied by ABPP?

Examples include serine hydrolases, cysteine proteases, DUBs, kinases, metalloproteases, proteasome-related enzymes, and other probe-covered families. Feasibility depends on probe availability and project goals.

Q: Do I need a family-selective activity-based probe?

In most cases, yes. The probe is central to the workflow. If probe suitability is unclear, we can review the enzyme family, sample type, and desired readout before project launch.

Q: Can this service compare inhibitor-treated and control samples?

Yes. Inhibitor-treated versus control comparison is a common design for evaluating family-wide selectivity and same-family off-target effects.

Q: Can Enzyme Family ABPP identify same-family off-targets?

Yes, when the probe, competition design, and LC-MS/MS depth support it. Same-family off-targets should still be validated by orthogonal assays.

Q: What controls are needed for enzyme family ABPP?

Common controls include vehicle control, no-probe control, probe-only group, inhibitor-treated group, dose or competition groups, and biological replicates.

Q: What is the difference between protein-level and site-level evidence?

Protein-level evidence identifies enzyme family members affected by labeling or competition. Site-level evidence identifies specific probe-labeled peptides or active-site regions where the workflow supports it.

Q: How should I interpret a family member that is not detected?

Non-detection does not automatically mean lack of activity. It may reflect probe coverage, enzyme abundance, sample preparation, site accessibility, enrichment efficiency, or MS depth.

Q: How do I choose between Enzyme Family ABPP, Competitive ABPP, and biochemical assays?

Choose Enzyme Family ABPP when the enzyme family is the central question. Choose Competitive ABPP when inhibitor occupancy and selectivity are the key endpoints. Choose biochemical assays for focused validation of selected enzymes.

Start an Enzyme Family ABPP Feasibility Review

If you need to profile activity, selectivity, or same-family off-targets within a selected enzyme family, we can help you determine whether enzyme family ABPP is the right next step.

Share your enzyme family, sample type, probe or inhibitor, treatment design, controls, and desired readout. Our team will review feasibility, recommend a workflow, and define the data package needed for interpretable family-wide ABPP results.

Disclaimer

This service is for Research Use Only and is not intended for clinical diagnosis, treatment selection, or medical decision-making.

Online Inquiry

Please submit a detailed description of your project. We will provide you with a customized project plan to meet your research requests. You can also send emails directly to for inquiries.

* Email
Phone
* Service & Products of Interest
Services Required and Project Description